Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-12 Karp Daniel EVP, Corporate Development Exercise or conversion +960 1,224.39
2020-02-12 Karp Daniel EVP, Corporate Development Shares withheld for taxes −294 $331.76 $98K 930.39
2020-02-12 Karp Daniel EVP, Corporate Development Exercise or conversion · Restricted Stock Unit −960 5,300
2020-02-12 Karp Daniel EVP, Corporate Development Other disposition · Restricted Stock Unit −1,126 4,174
2020-02-12 Karp Daniel EVP, Corporate Development Grant or award · Restricted Stock Unit +6,030 6,030
2019-07-02 Karp Daniel EVP, Corporate Development Exercise or conversion +196 322.39
2019-07-02 Karp Daniel EVP, Corporate Development Shares withheld for taxes −58 $236.37 $14K 264.39
2019-07-02 Karp Daniel EVP, Corporate Development Exercise or conversion · Restricted Stock Unit −196 1,564
2019-07-02 Karp Daniel EVP, Corporate Development Other disposition · Restricted Stock Unit −390 1,174
2019-02-12 Karp Daniel EVP, Corporate Development Grant or award · Restricted Stock Unit +6,260 6,260
2018-07-02 Karp Daniel EVP, Corporate Development Grant or award · Restricted Stock Unit +1,760 1,760

Page 1 of 1 · 11 trades